Effects of cardioselective beta adrenoceptor blockade on specific airways resistance in normal subjects and in patients with bronchial asthma

Clinical Pharmacology and Therapeutics
B N SinghE A Harris


The effects of single oral doses of the cardioselective beta adrenoceptor blocking drugs, metoprolol and tolamolol, on specific airways resistance (SRaw) were compared with those of propranolol and practolol in 6 healthy volunteers and in 12 patients with bronchial asthma. Whole-body plethysmography was used to measure SRaw and the blocking potency of different antagonists assessed by the degree of inhibition of tachycardia due to exercise on a treadmill. The changes correlated with plasma drug levels. Propranolol and practolol were measured fluorometrically and metoprolol by electron-capture gas-liquid chromatography. In normal subjects, about 30% reduction in exercise-induced tachycardia resulted from single doses of 80 mg propranolol (plasma levels, 50.3, SD, 29.5 to 60.8, SD, 26 ng/ml), 250 mg practolol (plasma levels, 1.05, SD, 0.32 to 1.10, SD, 0.55 mug/ml), 100 mg metoprolol (plasma levels, 137, SD, 111 to 152, SD, 100 ng/ml), and 100 mg tolamolol. In patients, these doses of the drugs produced significant increases in SRaw. These increases were greater than those after placebo but significantly so only during the peak effect 1 hr after propranolol. Compared with changes after placebo, significant effects on SRaw were al...Continue Reading


Jun 1, 1978·British Journal of Clinical Pharmacology·C R Kumana, R Ruffin
Jan 1, 1979·The Journal of International Medical Research·G Prager
Jan 1, 1987·European Journal of Clinical Pharmacology·P DescheJ F Prost
Mar 1, 1986·Journal of Clinical Pharmacology·D SheppardA Laddu
Jan 1, 1982·Acta Anaesthesiologica Scandinavica. Supplementum·K E Andersson
Jul 1, 1984·Drug Intelligence & Clinical Pharmacy·C D Black, H J Mann
Jan 1, 1984·European Journal of Clinical Pharmacology·H W ClagueS G Carruthers
Dec 22, 2007·American Journal of Respiratory Cell and Molecular Biology·Long P NguyenRichard A Bond
Jan 25, 2020·Human Vaccines & Immunotherapeutics·Else Marit Inderberg, Sébastien Wälchli
Mar 17, 1978·European Journal of Clinical Pharmacology·G CoccoF Follath
Jan 1, 1982·British Journal of Clinical Pharmacology·R E RuffinJ H Alpers
Dec 1, 1983·British Journal of Clinical Pharmacology·W M EdmondstoneD M Denison
Aug 24, 1999·Pharmacotherapy·M J Tafreshi, A B Weinacker
Jan 10, 2003·The Cochrane Database of Systematic Reviews·S SalpeterE Salpeter
Jan 28, 2009·Proceedings of the National Academy of Sciences of the United States of America·Long P NguyenRichard A Bond
Jun 13, 2009·American Journal of Respiratory Cell and Molecular Biology·David R Curran, Lauren Cohn
Nov 11, 2009·Current Eye Research·Igor KaisermanShlomo Vinker
Jun 19, 2001·The Cochrane Database of Systematic Reviews·S SalpeterE Salpeter

Related Concepts

Adrenergic beta-Antagonists
Airway Resistance
Pulse Rate
Plethysmography, Whole Body

Related Feeds


This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.